Loading
Supportive Care / Anatomic Stage III Breast Cancer AJCC V8 / Anatomic Stage Ii Breast Cancer AJCC V8 · Interventional Study
ClinicalTrials.gov · August 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record describing a planned feasibility trial of a blended e-health intervention to reduce fear of progression in women with gynecologic or breast cancer. No results are reported; the study is currently recruiting. The trial will evaluate recruitment rate, attrition, attendance, usability, engagement, and change in fear of progression over 12 weeks of follow-up.
Interventional, Randomized, Parallel, Triple masking, Supportive Care purpose. Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC…; Female; age from 18 Years. Intervention: Arm I (Mindful Living Program). Compared with: Arm II (Navigating Cancer Program) — Active Comparator. n = 126. 11 sites: United States.
This is a registry record describing a planned feasibility trial of a blended e-health intervention to reduce fear of progression in women with gynecologic or breast cancer. No results are reported; the study is currently recruiting. The trial will evaluate recruitment rate, attrition, attendance, usability, engagement, and change in fear of progression over 12 weeks of follow-up.
No results posted; study is actively recruiting and no efficacy or safety data are reported in this registry record
Clinicians should not change practice based on this registry entry, as no efficacy data are available. Once results are published, this work may inform feasibility and acceptability of remote psychological intervention for cancer-related fear of progression, an acknowledged unmet need.
This is a registry record for an active interventional feasibility study with no results yet posted; it describes planned enrollment and outcome measures only, making it a preliminary report of work in progress.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should not change practice based on this registry entry, as no efficacy data are available. Once results are published, this work may inform feasibility and acceptability of remote psychological intervention for cancer-related fear of progression, an acknowledged unmet need.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07741968). This is a study registration, not published results. Lead sponsor: City of Hope Medical Center. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 126 participants (ESTIMATED). Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma, Endometrial Carcinoma, Malignant Female Reproductive System Neoplasm, Ovarian Carcinoma, Ovarian Carcinosarcoma, Stage III Cervical Cancer AJCC v8, Stage III Vaginal Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Vaginal Cancer AJCC v8, Stage IV Vulvar Cancer AJCC v8, Triple-Negative Breast Carcinoma, Uterine Corpus Carcinosarcoma. Interventions: OTHER: Best Practice; OTHER: Interview; OTHER: Supportive Care; OTHER: Supportive Care; OTHER: Supportive Care; OTHER: Survey Administration; BEHAVIORAL: Telephone-Based Intervention. Primary outcome measures: Recruitment rate (Feasibility of enrollment) , Up to 18 months; Attrition rate (Intervention feasibility) , Up to 6 weeks; Percentage of Attendance/Sessions Completed , Up to 6 weeks; System Usability Scale survey (Acceptability) , At week 6 (T2); Engagement measures , Up to 6 weeks; Themes From Open-Ended System Usability Scale Responses and Open-Ended Exit Interview Questions , Up to 14 months; Change in fear of progression , At baseline (T1), 6 weeks (T2), and 12 weeks (T3). Brief summary: This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow, spread, or get worse. Managing FOP is a leading unmet concern of cancer patients. High levels of FOP are associated with distress, depression, and increased health care costs, despite this, access to resources to address FOP remain limited. The blended e-health intervention in this trial offers remote group sessions along with online sessions to help patients access the information. Session content incorporates values-based goal setting and skills practices to manage unhelpful beliefs about worry and promote helpful coping behaviors. The sessions may help patients recognize unhelpful thoughts and behaviors which reinforce worry. A blended e-health intervention may be an effective way to improve FOP in women with gynecologic or breast cancer.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.